David S. Johnson, MD, PhD

Clinical Assistant Professor, Psychiatry

(617) 638-4934
85 E. Newton St Fuller Building

Other Positions

  • Kaiser Permanente Santa Clara Medical Center

Education

  • University of California, San Diego, MD
  • University of California, San Diego, PhD
  • University of Utah, BS

Publications

  • Published on 8/1/1995

    Johnson DS, Martinez J, Elgoyhen AB, Heinemann SF, McIntosh JM. alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors. Mol Pharmacol. 1995 Aug; 48(2):194-9. PMID: 7651351.

    Read at: PubMed
  • Published on 4/1/1995

    Johnson DS, Heinemann SF. Embryonic expression of the 5-HT3 receptor subunit, 5-HT3R-A, in the rat: an in situ hybridization study. Mol Cell Neurosci. 1995 Apr; 6(2):122-38. PMID: 7551565.

    Read at: PubMed
  • Published on 1/16/1995

    Johnson DS, Heinemann SF. Detection of 5-HT3R-A, a 5-HT3 receptor subunit, in submucosal and myenteric ganglia of rat small intestine using in situ hybridization. Neurosci Lett. 1995 Jan 16; 184(1):67-70. PMID: 7739810.

    Read at: PubMed
  • Published on 11/18/1994

    Elgoyhen AB, Johnson DS, Boulter J, Vetter DE, Heinemann S. Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell. 1994 Nov 18; 79(4):705-15. PMID: 7954834.

    Read at: PubMed
  • Published on 2/10/1987

    Cruz LJ, Johnson DS, Olivera BM. Characterization of the omega-conotoxin target. Evidence for tissue-specific heterogeneity in calcium channel types. Biochemistry. 1987 Feb 10; 26(3):820-4. PMID: 2436655.

    Read at: PubMed

View all profiles